Literature DB >> 33204944

Thoracic duct decompression and jugular vein banding-an effective treatment option for protein-losing enteropathy and plastic bronchitis in severe failing Fontan circulation: a case report.

Christoph Bauer1, Roland Mair2, Rudolf Mair2, Gerald Tulzer1.   

Abstract

BACKGROUND: Plastic bronchitis (PB) and protein-losing enteropathy (PLE) are devastating complications after Fontan palliation that lead to uncontrolled loss of protein-rich lymphatic fluid into extra lymphatic compartments. Decompression of the thoracic duct is a new treatment option that effectively restores lymphatic system integrity by redirecting lymphatic flow into the low-pressure levels of the common atrium. CASE
SUMMARY: We report a patient with severe failing Fontan circulation where surgical thoracic duct decompression leads to resolution of PLE and PB symptoms but worsening hypoxaemia that could be managed with banding of internal jugular vein. DISCUSSION: Thoracic duct decompression in patients with failing Fontan circulation can be a simple and effective treatment for PLE and PB. Hypoxaemia may occur but can be managed with banding of internal jugular vein.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Case report; Fontan-operation; Hypoxaemia; Internal jugular vein banding; Plastic bronchitis; Protein-losing enteropathy; Thoracic duct decompression

Year:  2020        PMID: 33204944      PMCID: PMC7649443          DOI: 10.1093/ehjcr/ytaa170

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Thoracic duct decompression in severe failing Fontan circulation can be a highly effective simple and save treatment option for protein-losing enteropathy and plastic bronchitis. Profound cyanosis may develop after thoracic duct decompression but can be managed with banding of the internal jugular vein.

Introduction

Plastic bronchitis (PB) and protein-losing enteropathy (PLE) in single ventricle type congenital heart disease are devastating complications after surgical palliation. Pathophysiologic processes are still poorly understood. An increased central venous pressure, a hallmark of Fontan haemodynamic, seems to be the critical feature. As a consequence, lymph overproduction and congestion give rise to the formation of lymphatic fistulas and loss of protein-rich lymphatic fluid into extra lymphatic compartments., Current therapeutic strategies focus on interventional closure of such fistulas without considering and changing underlying pathophysiologic mechanism. A new approach, the decompression of the thoracic duct by creating a surgical anastomosis between the innominate vein and the atrial appendage overcomes this limitation as lymphatic flow is redirected into the low-pressure common atrium. However, as a consequence of creation of an iatrogenic right to left shunt profound cyanosis can be a challenge. We report a case where thoracic duct decompression in a patient with failing Fontan circulation almost normalized protein levels but lead to profound hypoxaemia that could be managed with banding of internal jugular vein.

Case presentation

A boy with a history of hypoplastic left heart syndrome who underwent the Norwood-, Glenn-, and an extracardiac fenestrated Fontan-operation at our facility presented at the age of 6 years with signs of PLE. Fenestration had been closed 3 years before after a trial occlusion demonstrated no reduction in cardiac output and no elevation of central venous pressure. He had hypoproteinaemia (total protein 3.6 mg/dL), hypogammaglobulinaemia (immunoglobulin G 86 mg/dL), leucopoenia (1.6 G/L), and elevated random stool α-1-antitrypsin level. During workup cytomegalovirus enterocolitis was diagnosed and hypoproteinaemia resolved after treatment with ganciclovir. However, 1 year later hypoproteinaemia recurred and initial treatment with budesonide transiently increased protein levels but had to be removed due to side effects. When the patient was admitted to our hospital with dyspnoea, hypoxaemia, and coughing at the age of 8 years, bronchoscopy was initiated and large branching casts were removed from both sides of the lung indicating PB. Cardiac catheterization at that time showed a mean central venous pressure of 12 mmHg and no evidence of obstruction to pulmonary artery flow or pulmonary vein stenosis and a mildly reduced right ventricular systolic function. Aortopulmonary collaterals were excluded (). Re-opening of the fenestration was considered at that time, but abandoned because parents disapproved the procedure and there was no obvious obstruction of pulmonary flow nor elevated central venous pressures. Lymphatic imaging via the lymph nodes demonstrated extensive lymph malformations that could not be treated with lymphatic intervention (). Fluoroscopy of the Fontan pathway demonstrating unobstructed pulmonary flow. Dynamic contrast magnetic resonance lymphangiography in a patient with severe failing Fontan circulation. Note the tortuous and dilated thoracic duct. Because of the severity of both conditions the patient was listed for cardiac transplantation. As bridging to transplant he underwent thoracic duct decompression as previously described by Hraška (). Creation of a surgical anastomosis between the innominate vein and the right atrial appendage. Procedure: A median sternotomy was performed. Right atrium, Fontan-tunnel, aortopulmonary truncus as well as the superior vena cava and the innominate vein were dissected. The innominate vein was mobilized up to the left venous angle, the left jugular vein and the left subclavian vein were dissected exclusively on the anterior surface. All residual venous branches which could be reached and were not ligated during Glenn-procedure were eliminated. Then, the right atrial appendage was mobilized. ECMO was used for venous drainage, the innominate vein and the aorta were cannulated. The innominate vein was crossclamped and transected at the junction with the right jugular vein. The proximal stump was oversewn. The apex of the right atrial appendage was clamped and incised. Muscle bundles and trabecula were resected and an end-end anastomosis with the innominate vein was performed. Surgery had immediate and dramatic effects on hypoproteinaemia (). Total protein and oxygen saturation profile after thoracic duct decompression and jugular vein banding in a patient with severe failing Fontan circulation. JVB: jugular vein banding; TDD: thoracic duct decompression. Total protein levels increased from 34 mg/dL preoperatively up to 68 mg/dL on the 8 post-operative day and normalized (72 mg/dL) during follow-up. However, arterial oxygen saturation measured by pulse oximetry dropped after the operation from 92–96% to 76–80% (). During the next 3 months the parents reported frequent saturations below 75% (home-measurement) and the patient complained of waxing fatigue. To improve hypoxaemia decision was made to decrease right to left shunt by banding the internal jugular vein. Procedure: The patient was placed in a supine position, the head slightly extended and turned to the right. The incision was performed along the anterior border of the sternocleidomastoid muscle, which was then retracted laterally. The vessels of the carotid triangle were exposed and the internal jugular vein was dissected free, especially in proximal direction. A banding, made of a 7 mm polytetrafluoroethylene prosthesis, was placed around the vein. The banding was than tightened until saturation increased just below 90% (). Banding of internal jugular vein. After banding the peripheral oxygen saturation was on average 85% in room air. Protein levels did not decrease and fatigue improved. Since thoracic duct decompression the patient had no further signs of PLE nor did he expectorate any casts and cardiac transplantation could be abandoned.

Discussion

Decompression of the thoracic duct either by creating a surgical anastomosis or by a transcatheter approach has previously been reported to be an effective treatment of severe lymphatic failure in a small number of patients. It is based on the concept of diverting blood from the innominate vein to the lower pressure systemic atrium and thereby reversing the deleteriously effects of venous congestion on lymphatic system integrity. Unlike selective lymphatic embolization of abnormal lymphatic fistulas, it modifies the pathophysiologic impetus and hence may have the potential to initiate long-standing improvement. In our patient symptoms and laboratory values improved dramatically so that he could be taken off transplant list. Profound hypoxaemia as a consequence of a new right to left shunt was a severe accompanying effect with a negative impact on quality of life. Banding of jugular vein allowed us to adjust venous flow and to achieve satisfactory oxygen saturation. The procedure itself was simple and safe. It had no effect on total protein levels and symptomatic and laboratory improvement persisted 6 months after the procedure.

Lead author biography

Dr Christoph Bauer graduated from Medical University of Graz, Austria in 2010. He completed his residency in Pediatric and Adolescent Medicine at the Kepler University Hospital. Currently, he is following his residency in Pediatric Cardiology at the Kepler University Hospital. His main research theme is Fontan failure in single ventricle patients.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Click here for additional data file.
AgeEvents
Past medical history: hypoplastic left heart syndrome, Norwood-OP (7days), Glenn-OP (3 months), extracardiac fenestrated Fontan-OP (3 years), closure of fenestration (3.5 years)
6 yearsDiagnosis of protein-losing enteropathy (PLE) (total protein 3.6 mg/dL), IgG 86 mg/dL, leucopoenia (1.6 G/L), elevated random stool α-1 antitrypsin level
Diagnosis of cytomegalovirus enterocolitis, treatment with ganciclovir improved hypoproteinaemia
7 yearsRecurrence of PLE (hypoproteinaemia)
Initial treatment with budesonide transiently increased protein levels but had to be removed due to side effects
8 yearsDiagnosis of plastic bronchitis (PB) (dyspnoea, hypoxaemia, and coughing, removal of large branching casts during bronchoscopy)
8 years 1 monthLymphatic imaging via the lymph nodes/patient was listed for heart transplantation
8 years 7 monthsThoracic duct decompression
Protein levels increased from 34 mg/dL preoperatively up to 72 mg/dL during follow-up but oxygen saturation dropped after the operation from 92–96% to 76–80%
8 years 11 monthsBanding of internal jugular vein
After banding peripheral oxygen saturation (SpO2) was on average 85% in room air. Protein levels did not decrease
Follow-up 6 months after bandingNo signs of PLE or PB. Fatigue improved. SpO2: 82%, total protein 70.4 mg/dL
  8 in total

1.  Decompression of thoracic duct: new approach for the treatment of failing Fontan.

Authors:  Viktor Hraška
Journal:  Ann Thorac Surg       Date:  2013-08       Impact factor: 4.330

2.  Protein-Losing Enteropathy in Patients With Congenital Heart Disease.

Authors:  Maxim Itkin; David A Piccoli; Gregory Nadolski; Jack Rychik; Aaron DeWitt; Erin Pinto; Jonathan Rome; Yoav Dori
Journal:  J Am Coll Cardiol       Date:  2017-06-20       Impact factor: 24.094

3.  Decompression of the thoracic duct: A novel transcatheter approach.

Authors:  Christopher L Smith; Timothy M Hoffman; Yoav Dori; Jonathan J Rome
Journal:  Catheter Cardiovasc Interv       Date:  2019-08-24       Impact factor: 2.692

4.  Thoracic Duct Decompression for Protein-Losing Enteropathy in Failing Fontan Circulation.

Authors:  Marta António; Andreia Gordo; Conceição Pereira; Fátima Pinto; Isabel Fragata; José Fragata
Journal:  Ann Thorac Surg       Date:  2016-06       Impact factor: 4.330

5.  Percutaneous Lymphatic Embolization of Abnormal Pulmonary Lymphatic Flow as Treatment of Plastic Bronchitis in Patients With Congenital Heart Disease.

Authors:  Yoav Dori; Marc S Keller; Jonathan J Rome; Matthew J Gillespie; Andrew C Glatz; Kathryn Dodds; David J Goldberg; Samuel Goldfarb; Jack Rychik; Maxim Itkin
Journal:  Circulation       Date:  2016-02-10       Impact factor: 29.690

6.  Percutaneous embolization of lymphatic fistulae as treatment for protein-losing enteropathy and plastic bronchitis in patients with failing Fontan circulation.

Authors:  Geert Maleux; Emma Storme; Bjorn Cools; Ruth Heying; Derize Boshoff; Jacoba J Louw; Stefan Frerich; Sofie Malekzadeh-Milanii; Jelena Hubrechts; Stephen C Brown; Marc Gewillig
Journal:  Catheter Cardiovasc Interv       Date:  2019-10-09       Impact factor: 2.692

7.  Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association.

Authors:  Jack Rychik; Andrew M Atz; David S Celermajer; Barbara J Deal; Michael A Gatzoulis; Marc H Gewillig; Tain-Yen Hsia; Daphne T Hsu; Adrienne H Kovacs; Brian W McCrindle; Jane W Newburger; Nancy A Pike; Mark Rodefeld; David N Rosenthal; Kurt R Schumacher; Bradley S Marino; Karen Stout; Gruschen Veldtman; Adel K Younoszai; Yves d'Udekem
Journal:  Circulation       Date:  2019-07-01       Impact factor: 29.690

Review 8.  The Relentless Effects of the Fontan Paradox.

Authors:  Jack Rychik
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2016
  8 in total
  3 in total

Review 1.  Lymphatic Disorders in Patients With Single Ventricle Heart Disease.

Authors:  Yoav Dori; Christopher L Smith
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

2.  Surgical and interventional rescue strategies for Fontan failure.

Authors:  Gregor Gierlinger; Eva Sames-Dolzer; Michaela Kreuzer; Roland Mair; Mohammad-Paimann Nawrozi; Andreas Tulzer; Christoph Bauer; Gerald Tulzer; Rudolf Mair
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-08-03

Review 3.  Transcatheter interventions in patients with a Fontan circulation: Current practice and future developments.

Authors:  Zakaria Jalal; Marc Gewillig; Younes Boudjemline; Patrice Guérin; Mara Pilati; Gianfranco Butera; Sophie Malekzadeh-Milani; Martina Avesani; Jean-Benoit Thambo
Journal:  Front Pediatr       Date:  2022-08-30       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.